However, further targeted research is needed to improve adherence to optimal care standards for patients from rural areas, such as the timeframe from initial referral to completion of investigations and MDT.Lachlan FitzpatrickTownsville Cancer Care Centre, Townsville, QLD, Australia...
From: The patient-breast cancer care pathway: how could it be optimized? Original Submission 22 Mar 2015 Submitted Original manuscript Resubmission - Version 2 Submitted Manuscript version 2 Author responded Author comments Resubmission - Version 3 Submitted Manuscript version 3 Publishing 5 May 2015 Ed...
Mono-allelic germline pathogenic variants in the Partner And Localizer of BRCA2 (PALB2) gene predispose to a high-risk of breast cancer development, consistent with the role of PALB2 in homologous recombination (HR) DNA repair. Here, we sought to define
Presentation and survival by hormonal receptor status in metaplastic breast cancer: A propensity score-matched analysis The Breast, Volume 60, 2021, pp. 168-176 Siqin Wang,…, Dan Shang View PDF Underutilisation of breast cancer prevention medication in Australia The Breast, Volume 60, 2021, pp...
Tumor cell dissemination in cancer patients is associated with a significant reduction in their survival and quality of life. The ubiquitination pathway plays a fundamental role in the maintenance of protein homeostasis both in normal and stressed conditions and its dysregulation has been associated with...
nicholas wilcken, department of medical oncology, university of sydney, westmead hospital, wentworthville nsw, australia • eric p. winer, breast oncology center, dana-farber cancer institute, boston, usa (chairman) • william c. wood, department of surgery, winship cancer institute, atlanta, ...
In oncology, the occurrence of distant metastases often marks the transition from curative to palliative care. Such outcome is highly predictable for breast cancer patients, even if tumors are detected early, and there is no specific treatment to prevent
Breast cancer is the second most frequent cancer in the world. It is a heterogeneous disease and the leading cause of cancer mortality in women. Advances in molecular technologies allowed for the identification of new and more specifics biomarkers for br
Breast cancer remains a worldwide public health dilemma and is currently the most common tumour in the globe. Awareness of breast cancer, public attentiveness, and advancement in breast imaging has made a positive impact on recognition and screening of b
This literature review aims to discuss the evidence surrounding (1) biomarkers for patient selection for NET, (2) the optimal neoadjuvant endocrine agent for postmenopausal women with locally advanced breast cancer, and (3) the optimal duration of NET. In addition, we make initial recommendations ...